The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Satralizumab
Australian Public Assessment Report
Device/Product Name
Enspryng
Active ingredients
Satralizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-04752-1-1
Submission Type
New biological entity
Decision
Approved